
FARALLON CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | RVMD | 13.60M | $1.32B |
![]() | EXEL | 13.11M | $562.33M |
![]() | BEAM | 10.13M | $241.51M |
![]() | ROIV | 9.68M | $268.00M |
![]() | BBIO | 9.37M | $695.48M |
![]() | TNGX | 9.10M | $190.32M |
![]() | LQDA | 8.66M | $326.68M |
![]() | CRNX | 8.34M | $302.84M |
![]() | BSX | 7.47M | $468.79M |
![]() | PTGX | 6.35M | $669.17M |
![]() | ARMK | 6.14M | $248.73M |
![]() | AGIO | 5.68M | $192.29M |
![]() | LNTH | 5.58M | $423.51M |
![]() | CNTA | 4.81M | $191.01M |
![]() | KKR | 4.67M | $432.14M |
![]() | AMZN | 4.22M | $878.56M |
![]() | SCHW | 3.96M | $371.75M |
![]() | BBNX | 3.61M | $36.15M |
![]() | TYRA | 3.58M | $137.15M |
![]() | GRAL | 3.25M | $168.15M |

Revolution Medicines, Inc.
RVMD
Shares Held
13.60M
Value
$1.32B

Exelixis, Inc.
EXEL
Shares Held
13.11M
Value
$562.33M

Beam Therapeutics Inc.
BEAM
Shares Held
10.13M
Value
$241.51M

Roivant Sciences Ltd.
ROIV
Shares Held
9.68M
Value
$268.00M

BridgeBio Pharma, Inc.
BBIO
Shares Held
9.37M
Value
$695.48M

Tango Therapeutics, Inc.
TNGX
Shares Held
9.10M
Value
$190.32M

Liquidia Corporation
LQDA
Shares Held
8.66M
Value
$326.68M

Crinetics Pharmaceuticals, Inc.
CRNX
Shares Held
8.34M
Value
$302.84M

Boston Scientific Corporation
BSX
Shares Held
7.47M
Value
$468.79M

Protagonist Therapeutics, Inc.
PTGX
Shares Held
6.35M
Value
$669.17M

Aramark
ARMK
Shares Held
6.14M
Value
$248.73M

Agios Pharmaceuticals, Inc.
AGIO
Shares Held
5.68M
Value
$192.29M

Lantheus Holdings, Inc.
LNTH
Shares Held
5.58M
Value
$423.51M

Centessa Pharmaceuticals plc
CNTA
Shares Held
4.81M
Value
$191.01M

KKR & Co. Inc.
KKR
Shares Held
4.67M
Value
$432.14M

Amazon.com, Inc.
AMZN
Shares Held
4.22M
Value
$878.56M

The Charles Schwab Corporation
SCHW
Shares Held
3.96M
Value
$371.75M

Beta Bionics, Inc.
BBNX
Shares Held
3.61M
Value
$36.15M

Tyra Biosciences, Inc.
TYRA
Shares Held
3.58M
Value
$137.15M

GRAIL, Inc.
GRAL
Shares Held
3.25M
Value
$168.15M
